Revitalizing monoamine oxidase inhibitors: a call for action

CNS Spectr. 2020 Aug;25(4):452-454. doi: 10.1017/S1092852919001196. Epub 2019 Jul 5.

Authors

P Ken Gillman¹, S Shalom Feinberg², Laura J Fochtmann³

Affiliations

¹ PsychoTropical Research, Queensland, Australia.
² Department of Psychiatry and Behavioral Science, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY, USA.
³ Departments of Psychiatry, Pharmacological Sciences and Biomedical Informatics, Stony Brook University, Stony Brook, NY, USA.

PMID: 31272520
DOI: 10.1017/S1092852919001196

No abstract available

Publication types

Editorial

MeSH terms

Antidepressive Agents / adverse effects
Antidepressive Agents / therapeutic use*
Depressive Disorder / drug therapy*
Expert Testimony
Humans
Monoamine Oxidase Inhibitors / adverse effects
Monoamine Oxidase Inhibitors / therapeutic use*
Practice Guidelines as Topic
Societies, Medical

Substances

Antidepressive Agents
Monoamine Oxidase Inhibitors